Advanced search
Publication Cover
Acta Cardiologica Volume 59, 2004 - Issue 2
Submit an article Journal homepage
3
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Paradoxical arterial and pulmonary embolism in a patient with a thrombus between atrial septum and patent foramen ovale

Katarzyna PiestrzeniewiczSterling Memorial Hospital, Cardiology Clinic, Institute of Cardiology, Sterlinga 1/3, 91-425 ™ódz, Poland.
&
Marek MaciejewskiSterling Memorial Hospital, Cardiology Clinic, Institute of Cardiology, Sterlinga 1/3, 91-425 ™ódz, Poland.Correspondence[email protected]
Pages 179-181 | Received 10 Mar 2003, Accepted 18 Mar 2003, Published online: 23 May 2017

References

  • Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, Glasgow GL. Patent foramen ovale in young stroke patients. Lancet 1988; 2: 11–2.
  • Hausmann D, Mugge A, Daniel WG. Identification of patent foramen ovale permitting paradoxical embolism. J Am Coll Cardiol 1995; 26: 1030–8.
  • Overell JR, Bone I and Lees KR. Interatrial septal abnor-malities and stroke: a meta-analysis of case-control studies. Neurology 2000; 55: 1172–9.
  • Labovitz AJ, Camp A, Castello R, Martin TJ, Ofili EO, Rickmeyer N, Vaughn M, Gomez CR. Usefulness of trans-esophageal echocardiography in unexplained cerebral ischemia. Am J Cardiol 1993; 72: 1448–52.
  • Travis JA, Fuller SB, Ligush J Jr, Plonk GW Jr, Geary RL, Hansen KJ. Diagnosis and treatment of paradoxical embolus. J Vasc Surg 2001; 34: 860–5.
  • Rachko M, Safi AM, Yeshou D, Pillai N, Salciccioli L, Stein RA. Cryptogenic ischemic stroke and paradoxical embolism: should a patent foramen ovale be closed? Case report and literature review. Angiology 2001; 52: 793–9.
  • De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, Beccia M, Calonnese C, Fedele F, Fieschi C, Pandian NG. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000; 31: 2407–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.